Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center,Multi-cohort,Prospective Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.

NCT06889610 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06889610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06889610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center,Multi-cohort,Prospective Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Recruiting
Start date
March 30, 2026
Completion date
December 30, 2028
Enrollment
95 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic, melanoma metastatic, triple negative breast cancer metastatic